Cargando…

Dysregulated metabolic enzymes and metabolic reprogramming in cancer cells

Tumor cells carry various genetic and metabolic alterations, which directly contribute to their growth and malignancy. Links between metabolism and cancer are multifaceted. Metabolic reprogramming, such as enhanced aerobic glycolysis, mutations in the tricarboxylic acid (TCA) cycle metabolic enzymes...

Descripción completa

Detalles Bibliográficos
Autores principales: Sreedhar, Annapoorna, Zhao, Yunfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772474/
https://www.ncbi.nlm.nih.gov/pubmed/29399334
http://dx.doi.org/10.3892/br.2017.1022
_version_ 1783293418077683712
author Sreedhar, Annapoorna
Zhao, Yunfeng
author_facet Sreedhar, Annapoorna
Zhao, Yunfeng
author_sort Sreedhar, Annapoorna
collection PubMed
description Tumor cells carry various genetic and metabolic alterations, which directly contribute to their growth and malignancy. Links between metabolism and cancer are multifaceted. Metabolic reprogramming, such as enhanced aerobic glycolysis, mutations in the tricarboxylic acid (TCA) cycle metabolic enzymes, and dependence on lipid and glutamine metabolism are key characteristics of cancer cells. Understanding these metabolic alterations is crucial for development of novel anti-cancer therapeutic strategies. In the present review, the broad importance of metabolism in tumor biology is discussed, and the current knowledge on dysregulated metabolic enzymes involved in the vital regulatory steps of glycolysis, the TCA cycle, the pentose phosphate pathway, and lipid, amino acid, and mitochondrial metabolism pathways are reviewed.
format Online
Article
Text
id pubmed-5772474
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-57724742018-02-02 Dysregulated metabolic enzymes and metabolic reprogramming in cancer cells Sreedhar, Annapoorna Zhao, Yunfeng Biomed Rep Review Tumor cells carry various genetic and metabolic alterations, which directly contribute to their growth and malignancy. Links between metabolism and cancer are multifaceted. Metabolic reprogramming, such as enhanced aerobic glycolysis, mutations in the tricarboxylic acid (TCA) cycle metabolic enzymes, and dependence on lipid and glutamine metabolism are key characteristics of cancer cells. Understanding these metabolic alterations is crucial for development of novel anti-cancer therapeutic strategies. In the present review, the broad importance of metabolism in tumor biology is discussed, and the current knowledge on dysregulated metabolic enzymes involved in the vital regulatory steps of glycolysis, the TCA cycle, the pentose phosphate pathway, and lipid, amino acid, and mitochondrial metabolism pathways are reviewed. D.A. Spandidos 2018-01 2017-11-21 /pmc/articles/PMC5772474/ /pubmed/29399334 http://dx.doi.org/10.3892/br.2017.1022 Text en Copyright: © Sreedhar et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Review
Sreedhar, Annapoorna
Zhao, Yunfeng
Dysregulated metabolic enzymes and metabolic reprogramming in cancer cells
title Dysregulated metabolic enzymes and metabolic reprogramming in cancer cells
title_full Dysregulated metabolic enzymes and metabolic reprogramming in cancer cells
title_fullStr Dysregulated metabolic enzymes and metabolic reprogramming in cancer cells
title_full_unstemmed Dysregulated metabolic enzymes and metabolic reprogramming in cancer cells
title_short Dysregulated metabolic enzymes and metabolic reprogramming in cancer cells
title_sort dysregulated metabolic enzymes and metabolic reprogramming in cancer cells
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772474/
https://www.ncbi.nlm.nih.gov/pubmed/29399334
http://dx.doi.org/10.3892/br.2017.1022
work_keys_str_mv AT sreedharannapoorna dysregulatedmetabolicenzymesandmetabolicreprogrammingincancercells
AT zhaoyunfeng dysregulatedmetabolicenzymesandmetabolicreprogrammingincancercells